posted
EDMONTON, Alberta, June 2, 2005 /PRNewswire-FirstCall via COMTEX/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has received regulatory approval to sell its VScan HIV test kits in the Ukraine. Market studies show that it is reasonable to expect that the Company will sell in excess of 750,000 HIV test kits in the first year. In addition to the approval in Ukraine, the Company expects that it will receive approval in several surrounding countries. Most of the rapid test kits for detection of HIV in this area are based on the identification of the IgG antibody which does not show up until 90 to 120 days after infection. By then the immune system has been seriously compromised. The VScan test kit detects the HIV exposure upon the formation of any of the antibodies (IgM, IgA, IgD, or IgG). Of the antibodies indicated, the first three all form before IgG. The first antibody that forms after the infection of HIV is IgM. IgM is detectable at the earliest stages (2 to 11 days) of viral infection before the immune system can be seriously compromised. It has been conclusively shown that the VScan rapid test kit detects the IgM antibody making it much more sensitive and specific to the detection of the HIV infection than any other HIV test kit on the market. The VScan HIV rapid test kit currently on the market that detects the IgM antibody. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com. NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. SOURCE Medical Services International Inc. Robert Talbot, +1-780-430-6363 or Bill Whitehead Jr., +1-416-822-5883, both of Medical Services International Inc.
Well, it will be interesting to see if the PPS goes up, down, or no movement based on the news. I have my hopes (up); have my fears (down); and have my expectations (essentially unchanged).
Laughing is therapeutic
-------------------- laughing is therapeutic
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
